Reappraisal of bicarbonate secretion by the human oesophagus

Gut

Volumn 40, Issue 5, 1997, Pages 582-586

  Mertz Nielsen, A ^a   Hillingso J ^a   Bukhave, K ^a   Rask Madsen, J ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Bicarbonate secretion; Oesophagus; Omeprazole; Ranitidine

Indexed keywords

BICARBONATE; OMEPRAZOLE; RANITIDINE;

ADULT; ARTICLE; CONTROLLED STUDY; ESOPHAGUS; FEMALE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PERFUSION; PRIORITY JOURNAL; SECRETION; VOLUNTEER;

EID: 0030923879     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.40.5.582     Document Type: Article

References (20)

1. Meyers RE, Orlando RC. In vivo bicarbonate secretion by human esophagus. Gastroenterology 1992; 103: 1174-6.
2. Brown CM, Snowdon CF, Slee B, Sandle LN, Rees WDW. Measurement of bicarbonate output from the intact human oesophagus. Gut 1993; 34: 872-80.
3. Helm JF, Dodds WJ, Hogan WJ, Soergel KH, Egide MS, Wood CM. Acid neutralizing capacity of human saliva. Gastroenterology 1982; 83: 69-74.
4. Helm JF, Dodds WJ, Pelc LR, Palmer DW, Hogan WJ, Teeter BC. Effect of esophageal emptying and saliva on clearance of acid from the esophagus. N Engl J Med 1984; 310: 284-8.
5. Helm JF, Dodds WJ, Hogan WJ. Salivary response to esophageal acid in normal subjects and patients with reflux esophagitis. Gastroenterology 1987; 92: 1393-7.
6. Mertz-Nielsen A, Hillingsø J, Bukhave K, Rask-Madsen J. Omeprazole promotes proximal duodenal mucosal bicarbonate secretion in humans. Gut 1996; 38: 6-10.
7. 2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis. Eur J Gastroenterology Hepathol 1995; 7: 467-75.
8. Wilde MI, McTavish D. Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders. Drugs 1994; 48: 91-132.
9. 2-adrenoceptor agonist clonidine. Gut 1989; 30: 1708-15.
10. Mertz-Nielsen A, Hillingsø J, Bukhave K, Rask-Madsen J. Indomethacin decreases gastroduodenal mucosal bicarbonate secretion in humans. Scand J Gastroenterol 1995; 30: 1100-5.
11. Kuo J, Fox E. Sigma Stat manual, microcomputer tools for the scientist. Revision SSD-1.0. Augsburg, Germany: Jandel Scientific, 1992.
12. Al Yassin TM, Toner PG. Fine structure of squamous epithelium and submucosal glands of human oesophagus. J Anat 1977; 123: 703-21.
13. Hamilton BH, Orlando RC. In vivo alkaline secretion by mammalian esophagus. Gastroenterology 1989; 97: 640-8.
14. Timmer R, Breumelhof R, Nadorp JHSM, Smout AJPM. Recent advances in the pathophysiology of gastrooesophageal reflux disease. Eur J Gastroenterol Hepatol 1993; 5: 485-91.
15. Dent J, Dodds WJ, Friedman RH, Sekiguchi T, Hogan WJ, Arndorfer RC, Petrie DJ. Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjects. J Clin Invest 1980; 65: 256-67.
16. Brown CM, Snowdon CF, Slee B, Sandle LN, Rees WDW. Effect of topical oesophageal acidification on human salivary and oesophageal alkali secretion. Gut 1905; 36: 649-53.
17. Sarosiek J, Hetzel DP, Yu Z, Piascik R, Li L, Rourk RM, McCallum RW. Evidence on secretion of epidermal growth factor by the esophageal mucosa in humans. Am J Gastroenterol 1993; 88: 108-17.
18. Collen MJ, Strong RM. Comparison of omeprazole and ranitidine in treatment of refractory gastroesophageal reflux disease in patients with gastric acid hypersecretion. Dig Dis Sci 1992; 37: 897-903.
19. Bate CM, Booth SN, Crowe JP, Mountford RA, Keeling PW, Hepworth-Jones B, et al. Omeprazole 10 mg or 20 mg once daily in the prevention of recurrence of reflux oesophagitis. Solo investigator group. Gut 1995; 36: 492-8.
20. Hallerback B, Unge P, Carling L, Edwin B, Glise H, Havu N, Lyrenäs E, Lundberg K. Omeprazole or ranitidine in long-term treatment of reflux esophagitis. The Scandinavian Clinics for United Research Group. Gastroenterology 1994; 107: 1305-11.